151 related articles for article (PubMed ID: 35067817)
21. The short-term outcome of laser in the management of female pelvic floor disorders: Focus on stress urine incontinence and sexual dysfunction.
Lin HY; Tsai HW; Tsui KH; An YF; Lo CC; Lin ZH; Liou WS; Wang PH
Taiwan J Obstet Gynecol; 2018 Dec; 57(6):825-829. PubMed ID: 30545535
[TBL] [Abstract][Full Text] [Related]
22. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause.
Gambacciani M; Levancini M; Russo E; Vacca L; Simoncini T; Cervigni M
Climacteric; 2018 Apr; 21(2):148-152. PubMed ID: 29436235
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of the use of fractional CO2RE intima laser treatment in stress and mixed urinary incontinence.
Palacios S; Ramirez M
Eur J Obstet Gynecol Reprod Biol; 2020 Jan; 244():95-100. PubMed ID: 31778906
[TBL] [Abstract][Full Text] [Related]
24. [Outcomes of ER:YAG LASER treatment of stress urinary incontinence in women].
Neimark AI; Yakovleva AY; Lapii GA
Urologiia; 2018 May; (2):20-25. PubMed ID: 29901290
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Er:YAG and CO
Li PC; Ding DC
Lasers Surg Med; 2023 Sep; 55(7):653-661. PubMed ID: 37265011
[TBL] [Abstract][Full Text] [Related]
26. Baseline ICIQ-UI score, body mass index, age, average birth weight, and perineometry duration as promising predictors of the short-term efficacy of Er:YAG laser treatment in stress urinary incontinent women: A prospective cohort study.
Fistonić I; Fistonić N
Lasers Surg Med; 2018 Jan; ():. PubMed ID: 29360142
[TBL] [Abstract][Full Text] [Related]
27. Comparison between erbium-doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence.
Okui N
World J Urol; 2019 May; 37(5):885-889. PubMed ID: 30116962
[TBL] [Abstract][Full Text] [Related]
28. Vaginal therapy of mild and moderate stress urinary incontinence using Er:YAG laser: a real treatment option.
Reisenauer C; Hartlieb S; Schoenfisch B; Brucker SY; Neis F
Arch Gynecol Obstet; 2019 Dec; 300(6):1645-1650. PubMed ID: 31612281
[TBL] [Abstract][Full Text] [Related]
29. Pixel CO
Franić D; Fistonić I; Franić-Ivanišević M; Perdija Ž; Križmarić M
Lasers Surg Med; 2021 Apr; 53(4):514-520. PubMed ID: 32896930
[TBL] [Abstract][Full Text] [Related]
30. Predictive factors for the efficacy of Er:YAG laser treatment of urinary incontinence.
Erel CT; Inan D; Mut A
Maturitas; 2020 Feb; 132():1-6. PubMed ID: 31883657
[TBL] [Abstract][Full Text] [Related]
31. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause.
Gambacciani M; Levancini M
Minerva Ginecol; 2015 Apr; 67(2):97-102. PubMed ID: 25763800
[TBL] [Abstract][Full Text] [Related]
32. The use of vaginal lasers in the treatment of urinary incontinence and overactive bladder, systematic review.
Alsulihem A; Corcos J
Int Urogynecol J; 2021 Mar; 32(3):553-572. PubMed ID: 33175226
[TBL] [Abstract][Full Text] [Related]
33. Fractional-Pixel CO
Alcalay M; Ben Ami M; Greenshpun A; Hagay Z; Schiff E
Lasers Surg Med; 2021 Sep; 53(7):960-967. PubMed ID: 32965724
[TBL] [Abstract][Full Text] [Related]
34. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence.
Gambacciani M; Torelli MG; Martella L; Bracco GL; Casagrande AG; Albertin E; Tabanelli S; Viglietta M; D'Ambrogio G; Garone G; Cervigni M
Climacteric; 2015; 18 Suppl 1():43-8. PubMed ID: 26366800
[TBL] [Abstract][Full Text] [Related]
35. Female urine incontinence:
Elia D; Gambiacciani M; Ayoubi JM; Berreni N; Bohbot JM; Descamps P; Druckmann R; Geoffrion H; Haab F; Heiss N; Rygaloff N; Russo E
Horm Mol Biol Clin Investig; 2020 Oct; 41(4):. PubMed ID: 33119542
[TBL] [Abstract][Full Text] [Related]
36. First assessment of short-term efficacy of Er:YAG laser treatment on stress urinary incontinence in women: prospective cohort study.
Fistonić N; Fistonić I; Lukanovič A; Findri Guštek Š; Sorta Bilajac Turina I; Franić D
Climacteric; 2015; 18 Suppl 1():37-42. PubMed ID: 26366799
[TBL] [Abstract][Full Text] [Related]
37. Periocular rejuvenation using a unique non-ablative long-pulse 2940 nm Er:YAG laser.
Badawi A; Sobeih T; Jasmina V
Lasers Med Sci; 2022 Mar; 37(2):1111-1118. PubMed ID: 34146192
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of vaginal laser therapy for stress urinary incontinence: a meta-analysis.
Wang Y; Wang C; Song F; Zhou Y; Wang Y
Ann Palliat Med; 2021 Mar; 10(3):2736-2746. PubMed ID: 33549008
[TBL] [Abstract][Full Text] [Related]
39. Rationale and design for fractional microablative CO
Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
[TBL] [Abstract][Full Text] [Related]
40. The efficacy of erbium-doped yttrium aluminum garnet (Er:YAG) laser in the treatment of decreased sexual sensation: a randomized, placebo-controlled trial.
Sathaworawong A; Manuskiatti W; Phatihattakorn C; Ungaksornpairote C; Ng JN
Lasers Med Sci; 2022 Feb; 37(1):581-588. PubMed ID: 33791888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
